Singapore markets closed
Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,895.85 +18.80 (+0.24%) Bitcoin USD
64,764.91 +1,945.62 (+3.10%) CMC Crypto 200
1,381.60 +68.98 (+5.26%)
Deciphera Pharmaceuticals, Inc. (DCPH)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:56PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.15B |
| Enterprise value | 869.45M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.41 |
| Price/book (mrq) | 3.28 |
| Enterprise value/revenue | 5.32 |
| Enterprise value/EBITDA | -4.16 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.39 |
| 52-week change 3 | -3.33% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 17.73 |
| 52-week low 3 | 9.90 |
| 50-day moving average 3 | 15.63 |
| 200-day moving average 3 | 14.05 |
Share statistics
| Avg vol (3-month) 3 | 528.02k |
| Avg vol (10-day) 3 | 427.87k |
| Shares outstanding 5 | 80.8M |
| Implied shares outstanding 6 | 80.8M |
| Float 8 | 41.98M |
| % held by insiders 1 | 30.49% |
| % held by institutions 1 | 73.54% |
| Shares short (28 Mar 2024) 4 | 6.06M |
| Short ratio (28 Mar 2024) 4 | 11.09 |
| Short % of float (28 Mar 2024) 4 | 9.99% |
| Short % of shares outstanding (28 Mar 2024) 4 | 7.50% |
| Shares short (prior month 29 Feb 2024) 4 | 5.51M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -119.34% |
| Operating margin (ttm) | -106.10% |
Management effectiveness
| Return on assets (ttm) | -28.43% |
| Return on equity (ttm) | -56.29% |
Income statement
| Revenue (ttm) | 163.36M |
| Revenue per share (ttm) | 1.92 |
| Quarterly revenue growth (yoy) | 32.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -208.86M |
| Net income avi to common (ttm) | -194.94M |
| Diluted EPS (ttm) | -2.29 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 306.22M |
| Total cash per share (mrq) | 3.79 |
| Total debt (mrq) | 25.88M |
| Total debt/equity (mrq) | 7.37% |
| Current ratio (mrq) | 3.80 |
| Book value per share (mrq) | 4.36 |
Cash flow statement
| Operating cash flow (ttm) | -146.7M |
| Levered free cash flow (ttm) | -72.79M |
© 2024 Yahoo. All rights reserved.